HuGE Literature Finder
Records
1
-
4
The impact of cytochrome P450 3A5 genotype on early tacrolimus metabolism and clinical outcomes in lung transplant recipients. International journal of clinical pharmacy 2021 Dec . Du Wenwen, Wang Xiaoxing, Zhang Dan, Chen Wenqian, Zhang Xianglin, Li Pengm |
Genotypes associated with tacrolimus pharmacokinetics impact clinical outcomes in lung transplant recipients. Clinical transplantation 2018 Jun e13332. Calabrese Daniel R, Florez Rebecca, Dewey Katherine, Hui Christine, Torgerson Dara, Chong Tiffany, Faust Hilary, Rajalingam Raja, Hays Steven R, Golden Jeff A, Kukreja Jasleen, Singer Jonathan P, Greenland John |
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation. Cancer chemotherapy and pharmacology 2016 May . Yamashita Takaya, Fujishima Naohito, Miura Masatomo, Niioka Takenori, Abumiya Maiko, Shinohara Yoshinori, Ubukawa Kumi, Nara Miho, Fujishima Masumi, Kameoka Yoshihiro, Tagawa Hiroyuki, Hirokawa Makoto, Takahashi Nao |
Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation. The pharmacogenomics journal 2008 Aug 8 (4): 248-55. Woodahl E L, Hingorani S R, Wang J, Guthrie K A, McDonald G B, Batchelder A, Li M, Schoch H G, McCune J |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 16, 2022
- Content source: